Amicus Therapeutics Cash Flow Statement (2010-2025) | FOLD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-65.66M	-51.23M	-50.29M	-83.28M	-85.26M	-62.16M	-33.29M	-55.87M	-52.93M	-43.23M	-21.58M	-33.84M	-48.42M	-15.70M	-6.73M	14.74M	-21.69M	-24.42M	17.31M	1.69M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	20.35M	11.74M	11.84M	13.91M	30.65M	12.46M	14.77M	18.63M	34.89M	16.58M	16.51M	18.09M	30.80M	16.20M	18.69M	19.22M	25.17M	17.56M	18.09M	26.59M
Deferred Taxes (Quarter)								0.01M	-4.94M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	14.19M	-13.80M	4.39M	-4.30M	8.99M	0.28M	1.84M	-10.04M	12.81M	-6.83M	-3.40M	15.34M	16.72M	-16.64M	-7.13M	7.05M	-1.18M	-2.79M	17.83M	4.46M
Asset Writedowns and Impairment (Quarter)					6.62M					1.13M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-72.35M	-35.92M	-23.70M	-70.51M	-58.31M	-15.86M	-11.63M	-80.77M	-18.07M	-16.13M	-38.35M	3.46M	-29.70M	22.69M	-22.97M	-3.92M	7.76M	-26.53M	35.66M	16.25M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)	0.56M	0.65M	0.65M	0.64M	0.64M	0.66M	0.67M	0.67M	0.67M	0.69M	0.72M	0.54M	0.53M	0.56M	0.57M	0.60M	0.61M	0.63M	0.66M	0.68M
Depreciation & Amortization (CF) (Quarter)	1.60M	1.57M	1.52M	1.52M	1.41M	1.33M	1.29M	1.31M	1.26M	2.21M	2.23M	2.18M	2.15M	2.18M	2.17M	2.04M	1.84M	1.85M	1.87M	1.90M
Change in Working Capital
Change in Receivables (Quarter)	-0.84M	3.97M	3.25M	1.82M	1.00M	3.42M	3.00M	9.90M	1.37M	-4.07M	11.32M	11.49M	-9.56M	10.00M	8.64M	10.39M	-15.33M	12.49M	8.08M	0.61M
Change in Inventory (Quarter)	-0.74M	5.19M	-1.42M	4.77M	-1.81M	-1.73M	-1.38M	10.26M	3.16M	24.32M	14.75M	2.38M	1.68M	25.22M	34.73M	12.02M	8.29M	22.58M	36.32M	44.30M
Change in Accured Expenses (Quarter)	-40.19M	11.71M	6.42M	29.50M	-14.56M	37.23M	2.79M	-31.84M	-0.07M	31.69M	9.48M	8.09M	-24.48M	27.12M	-14.12M	-5.04M	3.65M	10.36M	30.63M	38.14M
Other Working Capital Changes (Quarter)	-7.67M	2.40M	-3.81M	15.00M	-3.33M	7.81M	1.10M	0.61M	-1.84M	14.10M	13.75M	-17.95M	5.34M	-19.30M	-14.26M	14.26M	3.60M	4.75M	-7.57M	0.59M
Investing Activities
Capital Expenditures (Quarter)	0.87M	-0.68M	0.14M	3.56M	0.07M	1.15M	-0.14M	2.68M	1.94M	-1.65M	5.41M	1.73M	1.11M	1.80M	0.36M	0.29M	0.21M	-0.04M	2.82M	-2.92M
Change in Acquisitions & Divestments (Quarter)	163.68M	95.09M	83.58M	81.70M	108.33M	75.73M	75.86M	76.01M	54.94M	71.90M	53.98M	16.40M	38.91M	23.43M	39.54M	15.90M	6.16M	10.99M	17.26M	16.86M
Cash from Investing Activities (Quarter)	86.56M	25.71M	34.57M	-68.09M	58.21M	26.29M	74.52M	-66.70M	36.26M	50.00M	35.77M	-23.96M	7.54M	-21.98M	34.27M	-20.39M	-32.86M	-5.78M	-1.30M	-6.49M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	8.83M	2.23M	201.11M	-0.10M	-8.15M	0.69M	-0.56M	0.56M	-7.83M	23.67M	37.62M	8.21M	-13.31M	-0.86M	18.19M	1.10M	-11.70M	-0.40M	-1.32M	14.03M
Additional items
Exchange Rate Effect (Quarter)	-1.15M	-0.29M	-2.70M	-0.91M	-3.38M	-9.09M	-20.66M	18.50M	1.51M	-8.19M	16.90M	-3.91M	-1.82M	-0.29M	-5.03M	3.11M	4.82M	9.99M	-1.20M	-0.33M
Change in Cash (Quarter)	21.89M	-8.26M	209.28M	-139.62M	-11.63M	2.04M	41.67M	-128.42M	11.87M	49.35M	51.94M	-16.20M	-37.28M	-0.44M	24.46M	-20.10M	-31.98M	-22.72M	31.84M	23.46M
Free Cash Flow (Quarter)	-73.22M	-35.25M	-23.84M	-74.07M	-58.39M	-17.02M	-11.49M	-83.45M	-20.01M	-14.49M	-43.76M	1.73M	-30.80M	20.89M	-23.33M	-4.20M	7.55M	-26.49M	32.84M	19.18M
Net Cash Flow (Quarter)	23.04M	-7.97M	211.99M	-138.71M	-8.26M	11.12M	62.33M	-146.92M	10.36M	57.54M	35.04M	-12.29M	-35.47M	-0.14M	29.49M	-23.21M	-36.80M	-32.70M	33.04M	23.79M

Research Tools

Amicus Therapeutics Cash Flow Statement (2010-2025) | FOLD

Create an account

Sign In

Reset Password